PIM
BIIB icon

Profit Investment Management’s Biogen BIIB Stock Holding History

Profit Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-753
Closed -$206K – 96
2017
Q1 		$206K Sell
753
-480
-39% -$136K 0.17% 92
2016
Q4 		$350K Hold
1,233
– – 0.33% 88
2016
Q3 		$386K Sell
1,233
-300
-20% -$88.9K 0.38% 88
2016
Q2 		$371K Buy
1,533
+28
+2% +$7.38K 0.3% 90
2016
Q1 		$392K Hold
1,505
– – 0.17% 90
2015
Q4 		$461K Sell
1,505
-8,980
-86% -$2.58M 0.15% 87
2015
Q3 		$3.06M Sell
10,485
-680
-6% -$225K 0.45% 47
2015
Q2 		$4.51M Sell
11,165
-695
-6% -$279K 0.52% 43
2015
Q1 		$5.01M Hold
11,860
– – 0.27% 51
2014
Q4 		$4.03M Buy
11,860
+25
+0.2% +$8.09K 0.2% 64
2014
Q3 		$3.92M Hold
11,835
– – 0.2% 64
2014
Q2 		$3.73M Sell
11,835
-150
-1% -$45.1K 0.18% 68
2014
Q1 		$3.67M Hold
11,985
– – 0.17% 91
2013
Q4 		$3.35M Buy
11,985
+40
+0.3% +$10.3K 0.15% 95
2013
Q3 		$2.88K Sell
11,945
-920
-7% -$206K 0.12% 99
2013
Q2 		$2.77M Buy
+12,865
New +$2.75M 0.13% 103

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Profit Investment Management's BIIB Position: Q2 2017 in Review

Profit Investment Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 753 shares — an estimated $206K sold.

Profit Investment Management first reported a position in BIIB in Q2 2013 and held it in 16 quarters. The position peaked at $5.01M in Q1 2015. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Profit Investment Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Profit Investment Management sold 753 Biogen shares in Q2 2017, an estimated $206K.
  • Profit Investment Management first reported a position in Biogen in Q2 2013 and held it in 16 quarters.
  • Profit Investment Management's Biogen position peaked at $5.01M in Q1 2015.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Profit Investment Management's 13F filing for Q2 2017, filed 19 Jul 2017.